| Record ID | ia:isbn_9780521864558 |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/isbn_9780521864558/isbn_9780521864558_marc.xml |
| Download MARC binary | https://www.archive.org/download/isbn_9780521864558/isbn_9780521864558_meta.mrc |
LEADER: 01573pam a22004454a 4500
001 013943675
003 MiU
005 20151021000000.0
008 060125s2006 nyu 001 0deng
010 $a2006002543
020 $a0521864550$q(hbk.)
020 $a0521683831$q(pbk.)
024 3 $a9780521864558
024 3 $a9780521683838
035 $aMiU-BA.b2508631
035 $a(OCoLC)63179037
040 $aDLC$cDLC$dYDX$dUKM$dBAKER$dCOO$dIG#
042 $apcc
043 $an-us---
050 00 $aHD9666.9.M4$bV34 2006
100 1 $aVagelos, P. Roy.
245 14 $aThe moral corporation--Merck experiences /$cP. Roy Vagelos, Louis Galambos.
260 $aNew York, NY :$bCambridge University Press,$c2006.
300 $aix, 185 p. ;$c24 cm
500 $aIncludes index.
504 $aIncludes bibliographical references and index.
505 0 $aThe puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards.
610 20 $aMerck & Co.$xManagement.
650 0 $aPharmaceutical industry$xMoral and ethical aspects$zUnited States.
600 10 $aVagelos, P. Roy.
650 0 $aBusiness ethics.
650 0 $aSocial responsibility of business.
700 1 $aGalambos, Louis.
852 0 $aMiU$bSTATE$cBUS$hHD9666.9.M4V34 2006$xTransfer from Kresge 20151021
970 $aBK$bBook
971 $aMiU
972 $c20151021
973 $aAC$bavail_circ
974 $a35128002575981$bSTATE$cBUS$f01
997 $aMARS